There is an increasing momentum in research and pharmaceutical industry communities to
design sustained, non-invasive delivery systems to treat chronic neovascular ocular …

Age-related macular degeneration (AMD) is a leading cause of vision loss in the elderly. The
current standard treatment for AMD involves frequent intravitreal administrations of …

Neovascular eye diseases include conditions such as retinopathy of prematurity,
proliferative diabetic retinopathy, and neovascular age-related macular degeneration …

Patients with wet age-related macular degeneration (AMD) require intravitreal injections of
bevacizumab (Bev) or other drugs, often on a monthly basis, which is a burden on the …

There has been growing discovery and use of therapeutic peptides in drug delivery and
tissue engineering. Peptides are smaller than proteins and can be formulated into drug …

Porous ceramic microspheres are a desirable substance for bone tissue reconstruction and
delivery applications. This study focuses on Mg–Ca silicate microspheres encapsulated in …

The complexity of the human eye structure poses challenges in the diagnosis and treatment
of ocular diseases, especially the low efficiency of ocular drug delivery. With the continuous …

Introduction Masquelet proposed a new solution for the healing of segmental bone defects,
thus minimizing the disadvantages associated with traditional bone grafting. However, a …

In this study, drug carrier HCCP-PP-LEEMP microspheres were synthesized by using
Hexachlorocyclotriphosphazene (HCCP), Phenolphthalein (PP) and l-Lysine Ethyl Ester …

Recent preclinical and clinical studies have focused on the active area of therapeutic
peptides due to their high potency, selectivity, and specificity in treating a broad range of …